Tag: cse:lxx

January 21, 2019

Makers of Malboro Fund Lexaria’s Oral Nicotine Project

In a recent announcement, Malboro cigarette makers Altria Group Inc. (NYSE:MO) have entered into an agreement to fund R&D of...
December 3, 2018

Lexaria Bioscience: Out-licensing Patented Biotechnologies

Lexaria Bioscience Corp. (CSE:LXX,OCTQX:LXRP) has launched its campaign on the Investing News Network’s Cannabis and Life Science channels.
November 13, 2018

Lexaria Bioscience Launches ChrgD+

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the launch of ChrgD+, a...
October 31, 2018

Lexaria Bioscience Announces Increased Size and Closing of Private Placement

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that due to strong demand it...
April 10, 2017

Lexaria and NeutriSci Complete Cannabinoid Joint Venture

Lexaria Bioscience (OTCQB:LXRP,CSE:LXX) and NeutriSci International Inc. have completed and signed the previously announced joint venture agreement to produce and...
April 6, 2017

Lexaria Approaches Tipping Point with New Products & Financing

Lexaria Bioscience (OTCQB:LXRP,CSE:LXX) recently announced the launch of its TurboCBD™ brand of enhanced, high-absorption, full-spectrum hemp oil capsules. The capsules...
April 5, 2017

Lexaria Bioscience Closes Brokered Private Placement

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) is pleased to announce that it has completed its previously announced brokered private...